What does this article add?
In our large-scale retrospective cohort study, we examined the effect of
atorvastatin, as a lipophilic statin, on outcomes of patients with
severe to critical form of COVID-19. In addition to decrease in
mortality, we observed lower risk of need of invasive mechanical
ventilation associated with atorvastatin administration and also shorter
hospital length of stay in patients who received atorvastatin.